Long-term acting and orally active vanadyl-methylpicolinate complex with hypoglycemic activity in streptozotocin-induced diabetic rats

Journal of Clinical Biochemistry and Nutrition

Volumn 23, Issue 2, 1997, Pages 113-129

  Fujimoto, Seiki ^a   Fujii, Kumiko ^a   Yasui, Hiroyuki ^a   Matsushita, Rokuji ^b   Takada, Jitsuya ^b   Sakurai, Hiromu ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Diabetes; Oral administration; Organ distribution; Vanadyl complex; Vanadyl methylpicolinate

Indexed keywords

EID: 0031403443     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.23.113     Document Type: Article

References (40)

1. Hopkins, L.L., Jr., and Mohr, H.E. (1971): Newer Trace Elements in Nutrition, ed. by Mertz, W., and Cornatzen, W.E., Marcel Dekker, New York, pp. 195-213.
2. Simons, T.J.B. (1979): Vanadate - A new tool for biologists. Nature, 281, 337-338.
3. Nechay, B.R., Nanninga, L.B., Nechay, P.S.E., Post, R.L., Grantham, J.J., Macara, I.G., Kubena, L.F., Phillips, T.D., and Nielsen, F.H. (1986): Role of vanadium in biology. Fed. Proc., 45, 123-132.
4. Cantley, L.G., Jr., Josephson, L., Warner, R., Yanagisawa, M., Lechene, C., and Guidotti, G. (1977): Vanadate is a potent (Na-K)-ATPase inhibitor found in ATP derived from muscle. J. Biol. Chem., 252, 7421-7423.
5. Nechay, B.R. (1984): Mechanisms of action of vanadium. Annu. Rev. Pharmacol. Toxicol., 24, 501-524.
6. Heylinger, C.E., Tahiliani, A.G., and McNeill, J.H. (1985): Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science, 227, 1474-1477.
7. Liu, H., and McNeill, J.H (1994): Effect of vanadium treatment on the alterations of cardiac glycogen phosphorylase and phosphorylase kinase in streptozotocin-induced chronic diabetic rats. Can. J. Physiol. Pharmacol., 2, 1537-1543.
8. Candura, S.M., Manzo, L., Marraccini, P., Coccini, T., and Tonini, M. (1994): Investigation into vanadate-induced potentiation of smooth muscle contractility in the rabbit isolated ileum. Life Sci., 54, 237-244.
9. Oeztuerk, Y., Yildizoglu-Ari, N., Pekiner, C., Oezcelikay, A.T., and Altan, V.M. (1994): Vanadate treatment reverses gastrointestinal complications in the streptozotocin-diabetic rats. Gen. Pharmacol., 25, 1109-1114.
10. Adachi, K., Endo, M., Nagata, M., and Tamai, A. (1995): Effects of vanadate on glucose metabolism in the lens of rats with streptozotocin-induced diabetes. Ketohexokinase and aldolase activities. Yonago Acta Med., 38, 117-124.
11. Cordera, R., Andraghetti, G., DeFronzo, R.A., and Rossetti, L. (1990): Effect of in vivo vanadate treatment on insulin receptor tyrosine kinase activity in partially pancreatectomized diabetic animals. Endocrinology, 126, 2177-2183.
12. Fantus, I.G., Kadota, S., Deragon, G., Foster, B., and Posner, B. (1989): Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry, 28, 8864-8871.
13. Green, A. (1986): The insulin-like effect of sodium vanadate on adipocyte glucose transport is mediated at a post insulin-receptor level. Biochem. J., 238, 663-669.
14. +)-ATPase inhibitor. J. Biol. Chem., 255, 5306-5312
15. Schechter, Y., and Karlish, S.J.D. (1980): Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (VI) ions. Nature, 284, 556-558.
16. Duckworth, W.C., Solomon, S., Liepnieks, J., Hamel, F.G., Hand, S., and Peavy, D.E. (1988): Insulin-like effects of vanadate in isolated rat adipocytes. Endocrinology, 122, 2285-2289.
17. Tamura, S., Brown, T.A., Dubler, R.E., and Larner, J. (1984): Insulin-like effect of vanadate on adipocyte glycogen synthase and on phosphorylation of 95,000 dalton subunit of insulin receptor. Biochem. Biophys. Res. Commun., 113, 80-86.
18. Brichard, S.M., and Henquin, J.C. (1995): The role of vanadium in the management of diabetes. Trends Pharmacol. Sci., 16, 265-270.
19. Shechter, Y. (1990): Insulin-mimetic effects of vanadate. Diabetes, 39, 1-5.
20. Meyerovitch, J., Farfel, Z., Sock, J., and Shechter, Y. (1987): Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. J. Biol. Chem., 262, 6658-6662.
21. Ramanadham, S., Mongold, J.J., Brownsey, R.W., Cros, G.H., and McNeill, J.H. (1989): Oral vanadyl sulfate in the treatment of diabetes mellitus in the rat. Am. J. Physiol., 257, B904-H911.
22. Sakurai, H., Tsuchiya, K., Nukatsuka, M., Sofue, M., and Kawada, J. (1990): Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats. J. Endocrinol., 126, 451-459.
23. Sakurai, H., Tsuchiya, K., Nukatsuka, M., Kawada, J., Ishikawa, S., Yoshida, H., and Komatsu, M. (1990): Insulin-mimetic action of vanadyl complexes. J. Clin. Biochem. Nutr., 8, 193-200.
24. McNeill, J.H., Yuen, V.G., Hoveyda, H.R., and Orvig, C. (1992): Bis(maltolato)-oxovanadium (IV) is a potent insulin mimic. J. Med. Chem., 35, 1489-1491.
25. Watanabe, H., Nakai, M., Komazawa, K., and Sakurai, H. (1994): A new orally active insulin-mimetic vanadyl complex: Bis(pyrrolidine-N-carbodithioato)oxovanadium (IV). J. Med. Chem., 37, 876-877.
26. Sakurai, H., Fujii, K., Watanabe, H., and Tamura. H. (1995): Orally active and long-term acting insulin-mimetic vanadyl complex: Bis(picolinato)oxovanadium (IV). Biochem. Biophys. Res. Commun., 214, 1095-1101.
27. Tamura, S., Brown. T.A., Whipple, J.H., Fujita-Yamaguchi, Y., Dubler, R.E., Cheng, K., and Larner, J. (1984): A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J. Biol. Chem., 259, 6650-6658.
28. Nakai, M., Watanabe, H., Fujiwara, C., Kakegawa, H., Satoh, T., Takada, J., Matsushita, R., and Sakurai, H. (1995): Mechanism on insulin-like action of vanadyl sulfate: Studies on interaction between rat adipocytes and vanadium compounds. Biol. Pharm. Bull., 18, 719-725.
29. Schwabe, U., Puchstein, C., Hannemann, H., and Sochtig, E. (1979): Activation of adenylate cyclase by vanadate. Nature, 277, 143-145.
30. Huckle, W.H., and Earp, H.S. (1994): Synergistic activation of tyrosine phosphorylation by o-vanadate plus calcium ionophore A23187 or aromatic 1,2-diols. Biochemistry, 33, 1518-1525.
31. Elberg, G., Li, J., and Shechter, Y. (1994): Vanadium activates or inhibits receptor and non-receptor protein tyrosine kinases in cell-free experiments, depending on its oxidation state. J. Biol. Chem., 269, 9521-9527.
32. Ueki, H., Yamasaki, Y., Higo, K., Motoyashiki, T., Kawabata, H., and Morita, T. (1995): Regulation of cyclic AMP phosphodiesterase activity by particulate protein tyrosine kinase and phosphotyrosine phosphatase activities sensitive to sodium orthovanadate. Biol. Pharm. Bull., 18, 214-218.
33. 2 in the vanadate-stimulated release of lipoprotein lipase activity. Biol. Pharm. Bull., 18, 347-349.
34. Aktan, F., and Nebioglu, S. (1994): Effect of vanadium compounds on calmodulin activity in experimental diabetes in rats. Can. J. Physiol. Pharmacol., 72, 753-758.
35. Strout, H.V., Vicario, P.P., Saperstein, R., and Slater, E.E. (1989): The insulin-mimetic effect of vanadate is not correlated with insulin receptor tyrosine kinase activity nor phosphorylation in mouse diaphragm in vivo. Endocrinology, 124, 1918-1924.
36. Hogeboom, G. (1955): Fractionation of cell components of animal tissues. Methods Enzymol., 1, 16-19.
37. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951): Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
38. Fantus, I.G., Ahmad, F., and Deragon, G. (1990): Vanadate augments insulin binding and prolongs insulin action in rat adipocytes. Endocrinology, 127, 2716-2725.
39. Shechter, Y., Shisheva, A., Lazar, R., Libman, J., and Shanzer, A. (1992): Hydrophobic carriers of vanadyl ions augment the insulinomimetic actions of vanadyl ions in rat adipocytes. Biochemistry, 31, 2063-2068.
40. Heydorn, K. (1983): Metal Ions in Biological Systems, Vol. 16, ed. by Sigel, H., Marcel Dekker, New York, pp. 123-138.